MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
MediGene Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 24.41M |
| September 30, 2019 | -0.0732M |
| June 30, 2019 | 1.781M |
| March 31, 2019 | 0.6325M |
| December 31, 2018 | 5.805M |
| September 30, 2018 | 12.54M |
| June 30, 2018 | -44.18M |
| March 31, 2018 | 3.614M |
| December 31, 2017 | 19.55M |
| September 30, 2017 | 5.152M |
| June 30, 2017 | -6.811M |
| March 31, 2017 | 0.2899M |
| December 31, 2016 | -0.5425M |
| September 30, 2016 | -1.095M |
| June 30, 2016 | 11.58M |
| March 31, 2016 | 0.6902M |
| December 31, 2015 | -42.67M |
| September 30, 2015 | -0.2911M |
| June 30, 2015 | -0.1162M |
| March 31, 2015 | -0.0596M |
| December 31, 2014 | -0.0519M |
| September 30, 2014 | -0.584M |
| June 30, 2014 | -0.4814M |
| March 31, 2014 | -0.0507M |
| December 31, 2013 | -0.1377M |
| Date | Value |
|---|---|
| September 30, 2013 | -0.0152M |
| June 30, 2013 | -0.0352M |
| March 31, 2013 | -0.0053M |
| December 31, 2012 | -0.0519M |
| September 30, 2012 | -0.0491M |
| June 30, 2012 | -0.0501M |
| March 31, 2012 | -0.1796M |
| December 31, 2011 | -0.1685M |
| September 30, 2011 | 2.285M |
| June 30, 2011 | -0.0248M |
| March 31, 2011 | -0.1752M |
| September 30, 2010 | -0.0421M |
| June 30, 2010 | -0.2116M |
| March 31, 2010 | -0.0898M |
| December 31, 2009 | -0.0135M |
| September 30, 2009 | 0.7269M |
| June 30, 2009 | -0.2233M |
| March 31, 2009 | -0.1563M |
| December 31, 2008 | -0.8827M |
| September 30, 2008 | 6.964M |
| June 30, 2008 | -0.1495M |
| March 31, 2008 | -0.2051M |
| December 31, 2007 | -1.236M |
| September 30, 2007 | -0.2369M |
| June 30, 2007 | -0.1528M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| InflaRx NV | 14.90M |
| BioNTech SE | -118.82M |
| Immatics NV | -9.277M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |